Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease
- PMID: 24748893
- PMCID: PMC3989734
- DOI: 10.5812/hepatmon.14112
Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease
Abstract
Background: Elevated aminotransferases serve as surrogate markers of non-alcoholic fatty liver disease, a feature commonly associated with the metabolic syndrome. Studies on the prevalence of fatty liver disease in obese children comprise small patient samples or focus on those patients with liver enzyme elevation.
Objectives: We have prospectively analyzed liver enzymes in all overweight and obese children coming to our tertiary care centre.
Patients and methods: In a prospective study 224 healthy, overweight or obese children aged 1 - 12 years were examined. Body Mass Index-Standard Deviation Score, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl-transpeptidase were measured.
Results: Elevated alanine aminotransferase was observed in 29% of children. 26 % of obese and 30 % of overweight children had liver enzyme elevations. Obese children had significantly higher alanine aminotransferase levels than overweight children (0.9 vs. 0.7 times the Upper Limit of Normal; P = 0.04).
Conclusions: Elevation of liver enzymes appears in 29 % obese children in a tertiary care centre. Absolute alanine aminotransferase levels are significantly higher in obese than in overweight children. Even obese children with normal liver enzymes show signs of fatty liver disease as demonstrated by liver enzymes at the upper limit of normal.
Keywords: Child; Fatty Liver; Liver; Non-alcoholic Fatty Liver Disease; Obesity.
Figures


Similar articles
-
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22. Diabet Med. 2018. PMID: 29869810
-
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15. Diabet Med. 2017. PMID: 27334577
-
Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease.J Clin Lab Anal. 2020 Jul;34(7):e23285. doi: 10.1002/jcla.23285. Epub 2020 Apr 8. J Clin Lab Anal. 2020. PMID: 32267017 Free PMC article.
-
The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.J Pediatr Endocrinol Metab. 2017 Oct 26;30(11):1161-1168. doi: 10.1515/jpem-2017-0252. J Pediatr Endocrinol Metab. 2017. PMID: 28988228
-
Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.J Pediatr. 2015 Jun;166(6):1358-63.e1-3. doi: 10.1016/j.jpeds.2015.01.056. Epub 2015 Mar 11. J Pediatr. 2015. PMID: 25771388 Clinical Trial.
Cited by
-
The association of tonsillar microbiota with biochemical indices based on obesity and tonsillar hypertrophy in children.Sci Rep. 2023 Dec 20;13(1):22716. doi: 10.1038/s41598-023-49871-y. Sci Rep. 2023. PMID: 38123635 Free PMC article.
-
Screening for elevated risk of liver disease in preschool children (aged 2-5 years) being seen for obesity management.SAGE Open Med. 2014 Oct 14;2:2050312114555211. doi: 10.1177/2050312114555211. eCollection 2014. SAGE Open Med. 2014. PMID: 26770745 Free PMC article.
-
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE.PLoS One. 2019 May 22;14(5):e0216736. doi: 10.1371/journal.pone.0216736. eCollection 2019. PLoS One. 2019. PMID: 31116779 Free PMC article.
-
Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.Oxid Med Cell Longev. 2014;2014:469059. doi: 10.1155/2014/469059. Epub 2014 Nov 27. Oxid Med Cell Longev. 2014. PMID: 25544867 Free PMC article.
-
Predictive markers of metabolically healthy obesity in children and adolescents: can AST/ALT ratio serve as a simple and reliable diagnostic indicator?Eur J Pediatr. 2024 Jan;183(1):243-251. doi: 10.1007/s00431-023-05296-3. Epub 2023 Oct 23. Eur J Pediatr. 2024. PMID: 37870612
References
-
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources